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DNA methyltransferaseoping in the absence of the oocyte-derived DNA methyltransferase 1o (DNMT1o-
deﬁcient embryos) have signiﬁcant delays in development and a wide range of anatomical abnormalities. To
understand the timing and molecular basis of such variation, we studied pre- and post-implantation DNA
methylation as a gauge of epigenetic variation among these embryos. DNMT1o-deﬁcient embryos showed
extensive differences in the levels of methylation in differentially methylated domains (DMDs) of imprinted
genes at the 8-cell stage. Because of independent assortment of the methylated and unmethylated
chromatids created by the loss of DNMT1o, the deﬁcient embryos were found to be mosaics of cells with
different, but stable epigenotypes (DNA methylation patterns). Our results suggest that loss of DNMT1o in
just one cell cycle is responsible for the extensive variation in the epigenotypes in both embryos and their
associated extraembryonic tissues. Thus, the maternal-effect DNMT1o protein is uniquely poised during
development to normally ensure uniform parental methylation patterns at DMDs.
© 2008 Elsevier Inc. All rights reserved.IntroductionGenomic imprinting is an epigenetic process that distinguishes
parental alleles of a small number of genes that are essential for normal
mammalian development (McGrath and Solter, 1984; Surani et al.,
1984). In the post-implantation embryo and adult, parental alleles of
imprinted genes are transcribed differently (one allele is usually silent
and the other one expressed), and this difference in transcription is
associated with different epigenetic modiﬁcations (Lucifero et al.,
2002). These include different patterns of DNA cytosinemethylation to
generate differentially methylated domains (DMDs), as well as
differences in the histone modiﬁcations of the alleles' resident
nucleosomes (Carr et al., 2007; Delaval et al., 2007; Murrell et al.,
2004; Verona et al., 2008; Yang et al., 2003). All of these allelic
differences probably originate from processes that establish DNA
cytosine methylation patterns during germ cell development and
maintain some of the gametic methylation patterns during early
embryogenesis. DNMT3A, and its accessory protein DNMT3L are
important for establishing imprints in both germ lines, and disruptions
in this mechanism adversely affect embryonic and fetal development
(Bourc'his et al., 2001; Hata et al., 2002; Kaneda et al., 2004).l rights reserved.Less is known about the molecular mechanisms that ensure the
inheritance of imprinted methylation patterns following fertilization.
Inheritance of methylation imprints is necessary for normal develop-
ment and may be a critical component of a two-step process of
germline establishment and early embryonic maintenance of genomic
imprints. Some insight into the functional importance of preimplanta-
tion inheritance of genomic imprints has come from examining the
expression of DNMT1 proteins during this developmental window.
The Mr 190,000 DNMT1s protein is expressed at low levels in all
preimplantation cleavage stages, and at higher levels following
implantation (Cirio et al., 2008). This protein maintains methylation
patterns on DMD sequences in preimplantation staged embryos
(Hirasawa et al., 2008). The Mr 175,000 DNMT1o protein is also
expressed throughout preimplantation development; the protein is in
the cytoplasm of all preimplantation stage embryos, but in the nuclei
of only 8-cell embryos (Cardoso and Leonhardt, 1999; Carlson et al.,
1992; Doherty et al., 2002; Howell et al., 2001; Ratnam et al., 2002).
When the abundant DNMT1o protein is removed from the mouse
oocyte by deletion of the promoter governing synthesis of the Dnmt1o
transcript, DMD sequences still undergo de novo methylation during
oogenesis. However, post-implantation embryos derived from
DNMT1o-deﬁcient oocytes lose methylation on a signiﬁcant percen-
tage of the normally methylated alleles of their DMDs (Howell et al.,
2001). We concluded from these observations that DNMT1o is a
maternal-effect protein that is synthesized in the oocyte, stored in
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methylation at the 4th S phase in 8-cell embryos.
A recent report suggests that DNMT1o is not present in the nuclei
at any stage of preimplantation development (Hirasawa et al., 2008).
The apparent absence of nuclear DNMT1o in the Hirasawa et al. (2008)
study is puzzling because the same report conﬁrms the previous
ﬁnding of a genetic requirement for DNMT1o in maintaining DMD
methylation during preimplantation development (Howell et al.,
2001). Therefore, DNMT1o protein must come in contact with the
nuclear genome during preimplantation development, and based on
previous studies, we postulate this occurs during the 4th embryonic S
phase (8-cell embryos). Based on assumptions that DNMT1o functions
only in 8-cell blastomeres at the 4th S phase of embryogenesis, that
DMDs on many autosomes are similarly affected by the loss of
DNMT1o, and that chromosomes undergo independent assortment
during preimplantation development, we hypothesized that loss of
DNMT1o protein results in the generation of a multitude of epi-
genotypes (estimate of N4000) (Howell et al., 2001; Toppings et al.,
2008). If this model is correct, then each DNMT1o-deﬁcient embryo is
an epigenetic mosaic, composed of cells or epigenotypes with
fundamentally different genomic methylation patterns. Furthermore,
because each DNMT1o-deﬁcient embryo would be comprised of a few
epigenotypes out of the very large number of possible epigenotypes,
each embryo is very likely to be different from other DNMT1o-Fig. 1. DNMT1o is active in preimplantation development prior to the morula stage. Top: Sch
start of transcription and arrowheads indicate the tandem repeats within the Snurf/Snrpn D
Snrpn and H19 genes were analyzed with the bisulﬁte genomic sequencing technique in poo
DNMT1o-deﬁcient morulae were analyzed for each DMD. M=maternal allele; P=paternal
methylated CpG dinucleotides. The percentages of methylated CpGs are indicated. ⁎ denotes
differences (pb0.01). ns=not statistically signiﬁcant differences (pN0.05).deﬁcient embryos. This variability in epigenotypes offers one explana-
tion for the highly variable phenotypes observed among DNMT1o-
deﬁcient embryos of identical genetic backgrounds (Toppings et al.,
2008).
There are considerable effects on both DMD methylation and on
the phenotypes of embryos due to the loss of DNMT1o protein (Howell
et al., 2001; Toppings et al., 2008). Because of this, it is imperative to
understand the time at which DNMT1o functions to maintain DNA
methylation and to determine the molecular consequences of
DNMT1o loss on post-implantation embryos and placentae.
Results
DNMT1o maintains genomic imprints between the 4-cell and morula
stages
Because the DNMT1o protein is abundantly expressed during
preimplantation development, this developmental window is likely to
be the source of epigenetic defects in DNMT1o-deﬁcient embryos. For
this reason, we determined the preimplantation stage(s) at which the
absence of DNMT1o protein affects the inheritance of genomic
imprints. We ﬁrst compared patterns of allele-speciﬁc DNA methyla-
tion in wild-type and DNMT1o-deﬁcient morulae. F1 hybrid embryos
were obtained from crosses betweenwild-type andDnmt1Δ1o/Δ1o 129/Svematics of the mouse Snurf/Snrpn and H19 DMDs (grey boxes). The arrows represent the
MD. Bottom: Patterns of DNA methylation on DMD sequences of the endogenous Snurf/
ls of wild-type and DNMT1o-deﬁcient morulae. One pool of wild-type and two pools of
allele. Each line represents one sequenced allele. Filled circles indicate the position of
signiﬁcantly different levels of CpGs methylation (pb0.05). ⁎⁎ denotes highly signiﬁcant
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maternal and paternal alleles (Mann et al., 2003). Imprinted methyla-
tion patterns were determined at the Snurf/Snrpn and H19 DMDs
using the bisulﬁte genomic sequencing method. All examined
maternal alleles of the Snurf/Snrpn DMD were highly methylated and
all paternal alleles were hypomethylated in wild-type morulae (Fig. 1).
In contrast, there was a marked reduction of methylated maternal
Snurf/Snrpn alleles in DNMT1o-deﬁcient morulae. In a separate
experiment, we showed a similar level of methylation loss from
paternal alleles of the normally imprinted H19 DMD in DNMT1o-
deﬁcient morulae compared to wild-type embryos (Fig. 1). In all cases,Fig. 2. Time of DNMT1o activity during preimplantation development. (A) Schematic of the
regions of the mouse IgA locus (Ig) and the 3′ UTR and the c-myc exons (grey boxes) are show
methylation of the maternal TR2+3Igmyc transgene in wild-type and DNMT1o-deﬁcient
dinucleotides analyzed (open circles). The ﬁlled circles represent the position of methylated
on DNMT1o-deﬁcient MII oocytes (MII) and preimplantation embryos. 4=4-cell embryos; 8
indicated. Error bars represent standard error of the mean (SEM). ⁎ denotes signiﬁcantly d
(pb0.01). ns=not statistically signiﬁcant differences (pN0.05).there were alleles with an intermediate level of methylation (30–70%
methylated CpGs) that cannot be easily classiﬁed as “fully” methylated
or “unmethylated” alleles. These observations indicate that the
DNMT1o protein functions before the morulae stage to maintain
methylation on imprinted gene sequences. Because approximately
one-half of the normally methylated Snurf/Snrpn and H19 alleles had
lost methylation, it is possible that in the absence of DNMT1o protein,
there was a failure to maintain methylation of these DMDs at just one
cell cycle.
To more accurately determine when DNMT1o protein is catalyti-
cally active, we attempted to measure Snurf/Snrpn methylationTR2+3Igmyc transgene. The black box indicates Igf2r DMD sequences. The Cα and Sα
n. The arrows indicate the three primers used for semi-nested PCR. (B) Analysis of DNA
oocytes and preimplantation embryos. The top line shows the position of the CpG
CpG dinucleotides. (C) Summary of CpG methylation levels of the TR2+3Igmyc transgene
=8-cell embryos; M=morulae; Bl=blastocysts. The percentages of methylated CpGs are
ifferent levels of CpGs methylation (pb0.05). ⁎⁎ denotes highly signiﬁcant differences
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between homozygous Dnmt1Δ1o/Δ1o 129/Sv female mice and wild-
type CAST7 males. More often than not, these attempts failed because
of the absence of Snurf/Snrpn and/or H19 PCR ampliﬁcation products
using the bisulﬁte-treated DNA samples as templates. Even when PCR
products were obtained, such strong biases in the recovery of one
parental allele over the other (data not shown) were observed that we
were unable to reach any conclusions about the precise time of
DNMT1o function. We attributed these experimental failures to the
extremely small amounts of template genomic sequences obtained
from pools of preimplantation embryos, and likely to other confound-
ing factors speciﬁc to preimplantation embryos.
To circumvent the difﬁculties we encountered in measuring Snurf/
Snrpn and H19 DMD methylation on single-copy genomic sequences
in early-stage preimplantation embryos, we instead examined the
inheritance of DMD methylation of one of the many imprinted
transgenes we have constructed (Reinhart et al., 2002, 2006). The
advantages of using these imprinted transgenes for studies of
preimplantation DMD methylation are their presence in multiple
copies in the genome and their unambiguous inheritance as aFig. 3. DMD methylation in DNMT1o-deﬁcient ES Cells. (A) Methylation analysis of the Snurf
restriction map of the 5′-end of Snrpn gene is shown. Hybridization probe is indicated by th
(Hh) restriction enzymes. Lanes 1 to 6 are ESC clones from DNMT1o-deﬁcient line 1 (L1 Δ1o
clones fromDNMT1o-deﬁcient from L2Δ1o. RI=RI ES cells, c/c=Dnmt1c/c ES cells. Lanes 15 an
cells derivated from DNMT1o-deﬁcient (Δ1o) blastocysts. Left: A restriction map of the 5′ no
bar. Right: DNAs were digested with MspI (M) and HhaI (Hh) restriction enzymes. Lanes 1 to 1
unmethylated bands are shown. (C) Prediction of four chromosome 7 epigenotypes followin
appear in cells of 32-cell embryos after random assortment of chromatids. Each pair of vertic
indicates a parent-speciﬁc imprinted methylation mark on the normally methylated chromhemizygous locus from a single parent. The transgene we chose to
study in detail is designated TR2+3Igmyc (Fig. 2A). This imprinted
transgene contains Igf2r intronic DMD2 sequences on which mater-
nal-speciﬁc methylation is established during oogenesis, and then
maintained during preimplantation development (Reinhart et al.,
2006). TR2+3Igmyc models the acquisition and inheritance of a
maternal methylation imprint that occurs on endogenous mouse
Igf2r sequences (Brandeis et al., 1993). We observed that transgene
Igf2r DMD sequences were methylated in MII oocytes (Fig. 2B, left
panel). A similar level of methylation was present in 8-cell embryos
and in blastocysts that had inherited only TR2+3Igmyc maternal
alleles, consistent with the inheritance of oocyte TR2+3Igmyc
methylation. In contrast, when TR2+3Igmyc sequences were trans-
mitted through DNMT1o-deﬁcient oocytes, there was a loss of
methylation during preimplantation development (Fig. 2B, right
panel). Transgenic Igf2r sequences were highly methylated in
DNMT1o-deﬁcient MII oocytes and 4-cell embryos. However, in 8-
cell, morula and blastocyst stage embryos, there was a signiﬁcant
reduction in CpG methylation to ~50% of the number of methylated
CpGs in oocytes and 4-cell embryos (Fig. 2B, C). Many of the transgenic/Snrpn DMD on ES cells (ESC) derived from DNMT1o-deﬁcient (Δ1o) blastocysts. Left: A
e dark bar. Right: DNAs were digested with PstI (P) and the methylation sensitive HhaI
). Lane 7 is DNA from DNMT1o-deﬁcient ESC line 2 (L2 Δ1o) and lanes 8 to 12 are ESC
d 16 are ESC clones from awild-type line. (B)Methylation analyses of the H19DMD on ES
n-transcribed region of H19 gene is shown. Hybridization probe is indicated by the dark
6 same as in A. Molecular weights are expressed in kb and the expectedmethylated and
g loss of DNMT1o maintenance methylation at the fourth embryonic S phase; these ﬁrst
al lines (M=maternal, P=paternal) represents the two homologues of chromosome 7. m
osome.
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Snrpn and H19 genes in DNMT1o-deﬁcient morulae (Fig. 1), were not
easily classiﬁed as methylated or unmethylated. Nevertheless, the
percentage reduction was similar to the 46% reduction in maternal
Snurf/Snrpn methylation and 73% reduction in paternal H19 methyla-
tion seen in DNMT1o-deﬁcient morulae (Fig. 1). These ﬁndings are
consistent with DNMT1o maintenance methyltransferase activity
between the 4-cell and morulae stages. Based on previous observa-
tions that DNMT1o is present in nuclei of only 8-cell embryos
(Cardoso and Leonhardt, 1999; Carlson et al., 1992; Chung et al., 2003;
Doherty et al., 2002; Howell et al., 2001; Ratnam et al., 2002), this
result supports the notion that the functional requirement of DNMT1o
is associated with the single DNA replication cycle during the fourth S
phase of embryonic development.
DNMT1o-deﬁcient ES cell lines are mosaic for imprinted methylation
In a model inwhich each DNMT1o-deﬁcient embryo loses one-half
of DMD methylation during the fourth S phase, all embryos are
epigenetic mosaics (Howell et al., 2001; Toppings et al., 2008). An
alternative explanation however, for the loss of DMD methylation on
normally methylated alleles in pooled samples of either 8-cell
embryos, morulae or blastocysts (Figs. 1, 2) is that there is loss of
methylation in ~1/2 of the embryos but retention ofmethylation in the
other half. To distinguish between these two very different possibi-
lities, we examined Snurf/Snrpn and H19 DMD methylation in a series
of ES cell lines fromDNMT1o-deﬁcient 129/Sv blastocysts.We chose to
examine ES cells because they are the earliest developmental stage in
which individual cells (clones) can be compared and are representative
of the embryo's stem cells, which are established very soon after
DNMT1o's maintenance function. Using Southern blot analysis, we
determined that Snurf/Snrpn DMD methylation was lower in the
representative DNMT1o-deﬁcient ES cell line (L2 Δ1o) than in the
wild-type RI ES cell line, and signiﬁcantly greater than in the Dnmt1-Fig. 4. Retention of imprinted gene expression in DNMT1o-deﬁcient blastocysts. Allele-speci
wild-type and DNMT1o-deﬁcient blastocysts using real time RT-PCR. Expression of maternal
expression were determined as described in materials and methods.null (Dnmt1c/c) ES cell line (Fig. 3A, compare lanes 7, 13 and 14). The
reduction in the ratio of intensity of the methylated 1.9-kb and 0.9-kb
bands to the unmethylated 0.5-kb band in theDnmt1o-deﬁcient ES cell
line compared to the wild-type cell line indicates a signiﬁcant
reduction inmethylation. To determine if this reduction inmethylation
represents an epigenetic mosaicism, individual cell clones of two
DNMT1o-deﬁcient and onewild-type ES cell lines were examined.We
observed that ES clones distributed into two types: those with Snurf/
Snrpnmethylation similar to that seen in wild-type ES cell clones (Fig.
3A, compare lanes 4, 8, 10 and 12 to lanes 14 and 16), and those with a
hypomethylated pattern (Fig. 3A, compare lanes 1–3, 5, 6, 9 and 11 to
lane 14). Clones of wild-type ES cell lines with a hypomethylated
pattern were not seen. We conclude from this analysis of Snurf/Snrpn
DMD methylation that each DNMT1o-deﬁcient embryo is an epige-
netic mosaic comprised of two distinct Snurf/Snrpn epigenotypes.
An analysis of H19 DMD methylation showed a similar mosaic
pattern to that seen for the Snurf/Snrpn DMD. The samewild-type and
DNMT1o-deﬁcient ES cell lines were used for Snurf/Snrpn and H19
DMD methylation analysis. The methylation associated with the H19
DMD is on paternal chromosome 7, whereas the methylation
associated with the Snurf/Snrpn DMD is on maternal chromosome 7
(Lucifero et al., 2002; Tremblay et al., 1995). The DNMT1o-deﬁcient ES
cell line showed a similar reduction in H19 DMD methylation to the
reduction in Snurf/Snrpn DMDmethylation (Fig. 3B, lane 7), and clones
of the DNMT1o-deﬁcient lines were either normally methylated or
were hypomethylated (Fig. 3B, compare lanes 1, 2, 4–6, 8, 10–12 to
lanes 3 and 9). Despite alterations in Snurf/Snrpn and H19 DMD
methylation, all of the examined ES cell lines and clones showed
normal or nearly normal levels of LINE-1 and IAPmethylation (Fig. S1).
Similar ﬁndings were seen in a carefully analyzed post-implantation
embryo (Howell et al., 2001). Taken together, these observations
suggest that, of the sequences studied here, the only lasting genomic
effect of DNMT1o deﬁciency is the loss of methylation on imprinted
DMD sequences.ﬁc expression of H19, Snurf/Snrpn and Peg3 imprinted genes were analyzed in individual
allele is shown in red and expression of paternal allele is shown in blue. Percentages of
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and H19 DMD methylation (Fig. 3C). We recovered DNMT1o-deﬁcient
clones with epigenotype 1 (Fig. 3C) that showed normal Snurf/Snrpn
and H19 DMD methylation (lanes 4, 8,10 and 12), epigenotype 3 that
were hypomethylated on the Snurf/Snrpn DMD but methylated on the
H19 DMD, (lanes 1, 2, 5, 6 and 11) and epigenotype 4 that were
hypomethylated on both the Snurf/Snrpn and the H19 DMD (lanes 3
and 9). The inability to recover one of the four epigenotypes
(epigenotype 2 in Fig. 3C) could be due to the small number of clones
screened or the inability of epigenotype 2 to proliferate in culture.
We previously reported the isolation of this distinct epigenotype in
mouse embryonic ﬁbroblasts isolated from a DNMT1o-deﬁcient post-
implantation embryo, supporting the ﬁrst explanation (Toppings et al.,
2008).
Discordance between allele-speciﬁc methylation and expression in
DNMT1o-deﬁcient blastocysts
Because each DNMT1o-deﬁcient ES cell line we examined was an
epigenetic mosaic comprised of roughly equal numbers of cells with
normally imprinted methylation and loss of methylation at a
particular DMD, we assumed that each DNMT1o-deﬁcient blastocyst
was similarly composed. In principle, the cells in these mosaic
blastocysts that were unmethylated on both parental alleles of certainFig. 5. Variable loss of DMD methylation of E7.5 DNMT1o-deﬁcient embryos. Bisulﬁte genom
DMDs in E7.5 embryos. A representative wild-type and 4 different DNMT1o-deﬁcient em
dinucleotides are indicated by the ﬁlled circles. The percentages of methylated CpGs are ind
highly signiﬁcant differences (pb0.01). ns=not statistically signiﬁcant differences (pN0.05).DMDs should promote the biallelic expression of gene(s) regulated by
those DMDs. We tested this hypothesis by comparing the levels of
paternal- and maternal-allele expression of three genes (Snurf/Snrpn,
H19 and Peg3) known to be imprinted in blastocysts (Lucifero et al.,
2002; Shemer et al., 1997; Tremblay et al., 1995). As shown in Fig. 4,
H19 was expressed from only the maternal allele in wild-type as
well as DNMT1o-deﬁcient blastocysts. The Snurf/Snrpn gene also
showed an unexpected retention of imprinted gene expression in
blastocysts (Fig. 4). Although DNMT1o-deﬁcient blastocysts showed a
slight increase in the ratio of expression from the normally silent
maternal Peg3 allele compared to its paternal allele, the imprinted
expression of Peg3 was largely unaffected by the removal of DNMT1o
(Fig. 4). We conclude from these observations that, despite the
signiﬁcant reduction in DNAmethylation, there was no corresponding
change in expression from those parental alleles that have become
unmethylated in the absence of DNMT1o.
Imprinting abnormalities in E7.5 DNMT1o-deﬁcient embryos
The consistent loss of approximately one-half of DMDmethylation
in DNMT1o-deﬁcient ES cell lines (Fig. 3) suggests that each DNMT1o-
deﬁcient blastocyst had undergone the same or nearly the same loss in
DMD methylation. To determine if this overall mosaic composition is
maintained during further embryonic development, we measuredic sequencing was used to establish allele-speciﬁc methylation of H19 and Snurf/Snrpn
bryos are shown. M=maternal allele; P=paternal allele. Position of methylated CpG
icated. ⁎ denotes signiﬁcantly different levels of CpGs methylation (pb0.05). ⁎⁎ denotes
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embryos produced by crossing a homozygous Dnmt1Δ1o/Δ1o 129/Sv
female mouse and a CAST7 male mouse. DNA was extracted from the
entire E7.5 embryo for this analysis, and the ﬁndings were compared
to the allele-speciﬁc patterns of DNA methylation seen in wild-type
129/Sv X CAST7 F1 E7.5 embryos. We observed the expected pattern of
H19 (paternal allele methylated) and Snurf/Snrpn (maternal allele
methylated) DMD methylation in a representative wild-type embryo
(Fig. 5). This ﬁnding contrasts with the extent of H19 and Snurf/Snrpn
DMD methylation observed in six different E7.5 DNMT1o-deﬁcient
embryos (four embryos shown in Fig. 5). H19 and Snurf/Snrpn
methylation patterns of the DNMT1o-deﬁcient E7.5 embryos ranged
from normal or nearly normal to a complete absence of methylation.
In DNMT1o-deﬁcient embryos 1 and 2, H19 paternal methylation was
present on all examined alleles, whereas Snurf/Snrpn maternal
methylation was signiﬁcantly reduced. In embryo 3, there was a
partial loss of methylation on both DMDs, and in embryo 4, there was
a complete loss of DMD methylation. These ﬁndings indicate that
despite the consistent loss of approximately one-half of the methyla-
tion associated with the normally methylated parental alleles of H19
and Snurf/Snrpn in pools of DNMT1o-deﬁcient morulae/blastocysts
(Figs. 1, 2) and in DNMT1o-deﬁcient ES cell lines (Fig. 3), the extent of
methylation loss was not maintained into postimplantation develop-
ment. Rather, there was statistically signiﬁcant variation in the extentFig. 6. Allele-speciﬁc H19 methylation and expression in E9.5 DNMT1o-deﬁcient embryos a
deﬁcient embryos were determined by the method of bisulﬁte genomic sequencing. Allele
endonuclease digestion to distinguish parental alleles. M=maternal allele; P=paternal allele.
of methylated CpGs are indicated. ⁎ denotes signiﬁcantly different levels of CpGs methyla
signiﬁcant differences (pN0.05).of the measured epigenetic abnormalities among E7.5 embryos,
suggesting that there were events following the initial establishment
of mosaic preimplantation embryos that contributed to the cellular
composition of the post-implantation embryo.
Imprinting abnormalities in E9.5 DNMT1o-deﬁcient embryos
To better deﬁne the epigenetic variability among DNMT1o-
deﬁcient embryos, we also examined E9.5 embryos, a developmental
stage in where we could reliably measure effects of DNMT1o protein
loss in both embryos and placentae. In a representative wild-type
embryo, the H19 gene is expressed solely from the maternal allele in
both the embryo proper and in the placenta (Fig. 6), consistent with
previous studies (Tremblay et al., 1997). In the embryo, the maternal-
speciﬁc expression of H19 was tightly associated with paternal-
speciﬁc methylation, whereas in the placenta, the correlationwas less
precise. Although paternal H19 alleles were highly methylated in the
placenta, maternal H19 alleles exhibited variable degrees of methyla-
tion (Davis et al., 1998).
In contrast to the strict paternal-speciﬁc H19 DMD methylation
seen in control E9.5 embryos, DNMT1o-deﬁcient E9.5 embryos
exhibited variability in the extent of paternal-allele methylation.
DNMT1o-deﬁcient embryos 1 and 2 had an approximately normal
level of paternal-allele methylation, whereas approximately one-halfnd placentae. Methylation patterns of a representative wild-type and three DNMT1o-
-speciﬁc expression for H19 gene was analyzed using RT-PCR followed by restriction
Position of methylated CpG dinucleotides are indicated as ﬁlled circles. The percentages
tion (pb0.05). ⁎⁎ denotes highly signiﬁcant differences (pb0.01). ns=not statistically
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lated or hypomethylated. In all three embryos, there was biallelic
expression of H19, with variable ratios of maternal-to-paternal
expression. Abnormalities in DNA methylation and allele-speciﬁc
expression of H19 were also evident in the placentae of the three
mutant embryos. There was signiﬁcant loss of DNA methylation on
paternal alleles in two of the three placentae (DNMT1o-deﬁcient
placentae 2 and 3), and loss of monoallelic H19 expression in all three.
Notably, in the case of DNMT1o-deﬁcient embryo 2, there was a
marked degree of discordance between the extent of paternal-allele
methylation in the embryo and in the placenta.
Snurf/Snrpn methylation and expression were measured in the
same wild-type and DNMT1o-deﬁcient E9.5 embryos and placentae
used to measure H19 methylation and expression (Fig. S2). There
was strict maternal-speciﬁc methylation and paternal-speciﬁc
expression of Snurf/Snrpn in the wild-type embryo and its placenta,
but a high degree of variability in both allele-speciﬁc expression and
methylation among the three Dnmt1o-deﬁcient embryos examined
(Fig. S2). Whereas DNMT1o-deﬁcient embryo 1 exhibited nearly
normal patterns of allele-speciﬁc H19 methylation in both embryo
and placental tissue (Fig. 6), Snurf/Snrpn methylation was nearly
absent in both the embryo and placenta. The other two DNMT1o-
deﬁcient embryos also showed discordance between the extent of
allele-speciﬁc H19 and Snurf/Snrpn methylation in embryo and
placenta, although not to the extent seen in DNMT1o-deﬁcient
embryo 1 (Figs. 6, S2).
Discussion
Timing of DNMT1o function and random chromosome segregation as a
primary source of epigenetic variation
The ﬁndings presented here indicate that there are molecular and
cellular processes that work sequentially during embryogenesis to
produce epigenetic variation and a wide range of anatomical
phenotypes in DNMT1o-deﬁcient mice. The primary effect of
DNMT1o loss is the generation of preimplantation epigenetic mosaic
embryos. These are produced by the combined effects of a transient
loss of DNMT1o maintenance methyltransferase activity followed by
the normal process of random chromosome segregation (Fig. 7). WeFig. 7. Summary of molecular and cellular events leading to epigenetic mosaicism. The 12 au
blastomeres (left). Methylated DNA single strands are chromatids indicated by ﬁlled areas and
of chromatids following replication, cell division and cell distribution within embryo are shdeﬁne different epigenotypes by the different methylation states of
DMDs. Thus, mosaic embryos are comprised of cells with different
epigenotypes, with each unique epigenotype representing a collection
of normally methylated and unmethylated DMDs.
The duration of one cell cycle and the time of action are intriguing
aspects of DNMT1o deﬁciency. Because we observed that ~50% of
methylation remains on normally methylated DMDs in DNMT1o-
deﬁcient morulae and blastocysts (Figs. 1, 2), DNMT1o probably
functions at a single S phase. This is based on interpretation of mul-
tiple localization studies (Cardoso and Leonhardt, 1999; Carlson et al.,
1992; Doherty et al., 2002; Howell et al., 2001; Ratnam et al., 2002)
which concluded that DNMT1o protein localizes to the nuclei of 8-cell
blastomeres. The only reported exception to these results is the
negative staining for DNMT1o of 8-cell nuclei by Hirasawa et al.
(2008).
We interpret the 8-cell embryo nuclear localization and the timing
of DNMT1o's effect (Fig. 2) to mean that loss of methylation at the
fourth S phase, followed by DNA replication, maintenancemethylation
and chromosome segregation at the subsequent cell cycle, would
produce mosaics that are ﬁrst evident at the 32-cell stage. If loss of
maintenance methylation occurred for two or more cell cycles much
higher number of cells with unmethylated DMDs, and a much lower
number of distinct epigenotypes would result. Furthermore, loss of
maintenance methylation for a single cell cycle at a later stage of
preimplantation development, when many more cells are present,
would produce a mosaic embryo with much greater cell-to-cell
variation. Thus based on our data, we conclude that the timing of
DNMT1o function is at the 8-cell stage, consistent with the fact that
DNMT1o is only present in the nucleus at the 8-cell cleavage stage.
In light of this, questions arise as to why DNMT1o function at the
fourth embryonic S phase is necessary. There are two likely
possibilities. First, the 8-cell embryo is the latest embryonic stage in
which all cells are morphologically, and probably functionally
identical (Fleming et al., 2001; Pratt et al., 1982; Reeve and Ziomek,
1981), and maintenance methylation at a distinct S phase might only
be possible if all the cells are identical. Second, although cell-to-cell
epigenetic complexity is much less than maximal when maintenance
methylation is lost at the 4th S phase (as in a DNMT1o-deﬁcient
embryo), the embryo-to-embryo variation will be much greater
because each DNMT1o-deﬁcient embryo will have b1% of possibletosomes known to contain imprinted genes are depicted as colored bars in 8-cell stage
unmethylated DNA single strands and chromatids indicated by outlined areas. The fates
own.
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more identical epigenotypes is very low, and each DNMT1o-deﬁcient
embryo is likely to be very different from every other DNMT1o-
deﬁcient embryo.
In addition to transient loss of DNMT1o maintenance methyl-
transferase activity, random chromosome segregation likely plays a
major role in the generation of epigenetically mosaic embryos. In this
study, we examined the methylation status of two DMDs in DNMT1o-
deﬁcient preimplantation embryos. Four distinct Snurf/Snrpn-H19
chromosome 7 epigenotypes were predicted to occur according to a
model of random (independent) assortment of chromosome 7 sister
chromatids. This randomization of chromosome 7 maternal and
paternal epigenotypes would occur during anaphase of the cell cycle
immediately following the DNMT1o-dependent one (Fig. 3C). These
cellular epigenotypes would therefore ﬁrst appear in DNMT1o-
deﬁcient morula, a stage at or just preceding the appearance of cells
destined to become the deﬁnitive stem cells of the embryo. If, as
expected, all other chromosomes containing DMDs undergo random
assortment of their chromatids, we would expect a very large number
of epigenotypes to be produced due to the loss of DNMT1o protein
(Toppings et al., 2008). More speciﬁcally, as there are 12 autosomes
containing imprinted genes, we estimated that there are greater than
4000 possible epigenotypes that can be produced as a consequence of
DNMT1o deﬁciency (Toppings et al., 2008).
The severe epigenetic consequences of DNMT1o deﬁciency
indicate that preimplantation development is a potent source of
variation and that an important role of DNMT1o protein is in
precluding epigenetic variation. In light of this, we can speculate
that DNMT1o may, in some circumstances, be regulated in order to
increase epigenetic and phenotypic variation among embryos. For
example, a partial decrease in the level of DNMT1o in nuclei of 8-cell
embryos might increase epigenetic variation, but not lead to fetal
death. Epigenetic mosaicism has been reported in humans, and in a
pair of familial cases, pronounced phenotypic differences between
mosaic siblings was observed (Boonen et al., 2008). In this regard, it is
interesting to consider that a partial decrease in DNMT1o may
underlie epigenetic defects in mouse embryos cultured in various
synthetic media (Doherty et al., 2000; Khosla et al., 2001). Moreover,
there is evidence that cases of Beckwith–Wiedemann Syndrome
(BWS) associated with assisted reproductive technology (ART) are
epigenetic mosaics (DeBaun et al., 2003), consistent with an ART-
induced disruption in the normal process whereby inherited
methylation is maintained in the early embryo. Taken together,
observations on the highly variable phenotypes among DNMT1o-
deﬁcient mice and the emerging evidence of similar imprint-related
epigenetic mosaic humans indicate a need to understand the etiology
of these effects.
Discordance between loss of methylation and loss of expression in
DNMT1o-deﬁcient embryos
Another prominent message that emerges from our analysis of the
observed sources of phenotypic variation in DNMT1o-deﬁcient mice is
that there is a delay between the developmental time of methylation
loss and a change in allele-speciﬁc expression (Figs. 1, 2 and 4).
Methylation defects are present in both DNMT1o-deﬁcient blastocysts
and E9.5 embryos and yet we only observed biallelic expression of
imprinted genes in E9.5 embryos. Although we do not know when in
the intervening six days biallelic expression of chromosome 7
imprinted genes ﬁrst occurred, it likely takes place after implantation.
The mechanism of such discordance between imprinted methyla-
tion and expression might be the presence of other chromatin
modiﬁcations regulating expression of these genes. In a strict sense,
the parental alleles in a DNMT1o-deﬁcient blastocyst must be
distinguished by an epigenetic mark (other than DNA methylation)
that has an absolute controlling effect on transcription. We speculatethat there are differences between thematernal and paternal alleles in
the chromatin composition of the Snurf/Snrpn, H19 and Peg3 genes in
DNMT1o-deﬁcient blastocysts. Perhaps the relevant differences are
histone modiﬁcations that are known to distinguish the maternal and
paternal alleles in preimplantation-stage embryos (Liu et al., 2004;
Santos et al., 2005). Precedents for this type of effect have been
described in extraembryonic tissues of the mouse; imprinted genes
expressed only in the placentae and located in a cluster of imprinted
genes associated with the Kcnq1 gene remain imprinted even in
placentae of embryos homozygous for a null-allele of Dnmt1 (Dnmt1C
allele) (Lewis et al., 2004). Interestingly, in the absence of DNA
methylation, parental allele-speciﬁc differences in chromatin were
observed, suggesting that chromatin differences maintain an
imprinted state of imprinted gene expression in the absence of
DNMT1-dependent maintenance methylation. An alternative expla-
nation for the discordance between allele-speciﬁc DMD methylation
and expression is that the absence of DNMT1o has not affected
methylation patterns at locations in the H19 and Snurf/Snrpn genes
that control expression in blastocysts. However, because a concor-
dance between H19 and Snurf/Snrpn DMDmethylation and expression
is realized with further embryonic development, in this case the
absence of DNMT1o must eventually lead to more extensive
methylation changes in these genes.
Subsequent developmental events and the generation of variable
phenotypes
Epigenetic mosaicism may be related to the widely ranging
anatomical phenotypes seen in DNMT1o-deﬁcient embryos. Different
epigenotypes have different developmental potential, and cells with
abnormal epigenotypes have restricted developmental potentials
compared to cells with a normal epigenotype. Data from a variety of
experiments in the mouse support this notion. Uniparental disomies
can be produced experimentally in mice, and a given uniparental
disomy will reproducibly give rise to a consistent abnormal pheno-
type. For example, paternal uniparental disomy of chromosome 11 is
associated with a predictable effect on in utero growth. Fetal and
placental overgrowth was associated with paternal disomy and
maternal nullisomy for chromosome 11, whereas fetal and placental
growth retardation was associated with chromosome 11 maternal
disomy and paternal nullisomy (Cattanach and Kirk, 1985). Thus, the
chromosome 11 epigenotype predicts the outcome of fetal develop-
ment. Similar arguments can be made for the abnormal development
seen in gynogenotes and androgenotes (McGrath and Solter, 1984;
Surani et al., 1984). This includes the restricted distribution and
development of cells of uniparental origin in both gynogenic-
biparental and androgenic-biparental chimeras (Norris et al., 1990).
Our data also suggest that other processes, besides the altered
developmental potential of epigenotypes produced by the absence of
DNMT1o, may account for the wide range in phenotypes apparent in
DNMT1o-deﬁcient embryos (Fig. 7) (Toppings et al., 2008). We
observed a remarkable degree of statistically signiﬁcant variation in
the extent of DMD methylation among E7.5 and E9.5 DNMT1o-
deﬁcient embryos and placentae (Figs. 5, 6 and S2). For example,
whereas some DNMT1o-deﬁcient E7.5 and E9.5 embryos had normal
levels of H19methylation, other E7.5 and E9.5 embryos showed highly
signiﬁcant losses of H19 methylation. These differences in the degree
of variation in methylation between late-stage preimplantation and
post-implantation DNMT1o-deﬁcient embryos suggest that primary
mosaicism established in early development evolves through one or
more post-implantation processes to expand the range of molecular
defects associated with imprinted genes.
One explanation is the nonrandom distribution of cells of different
epigenotypes in the developing DNMT1o-deﬁcient embryo. Non-
random distribution of cells of different epigenotypes likely occurs
because these cell types are present at a very early stage of
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mosaics will most likely distribute to trophectoderm and inner cell
mass in a random fashion that could account for the observed
discordance inmethylation between embryo and placenta (Figs. 6, S2).
Non-random distribution of cells within a DNMT1o-deﬁcient embryo
may also account for the discordance between H19 and Snurf/Snrpn
expression and methylation (Figs. 6, S2) because expression and
methylation were measured in different sagital halfs. In conclusion,
although we cannot reach a ﬁrm conclusion about the source(s) of
embryo-to-embryo variation in methylation, there are some probable
explanations for this that extend beyond the events associated with
the initial generation of the epigenetic mosaics.
In summary, the primary effect of DNMT1o loss is the generation of
epigenetically mosaic embryos. While it is not known how DNMT1o
functions speciﬁcally during the 8-cell stage, it is clear that DNMT1o
function during this critical time cannot be compensated by other
methyltransferases (Chung et al., 2003; Cirio et al., 2008). Further
investigation is needed to determine whether disruptions in
DNMT1o-dependent maintenance methylation underlie cases of
DMD mosaicism associated with assisted reproduction technology
(ART) in humans and hybrid dysgenesis in mice (DeBaun et al., 2003;
Shi et al., 2005).
Materials and methods
Mouse genotyping and embryo collection
The mutant Dnmt1Δ1o allele (Howell et al., 2001) was maintained
in the inbred 129/Sv background, and the TR2+3Igmyc transgene was
maintained in the inbred FVB/N background (Reinhart et al., 2006).
Dnmt1Δ1o mice were genotyped using a PCR assay as previously
described (Howell et al., 2001). TR2+3Igmyc transgenic mice were
genotyped using a PCR assay in which the PCR primers spanned the
unique IgA-myc junction of the transgene construct: 5′-ctattccagcc-
tagtctgct-3′ (IgA) and 5′-agtcagaagctacggagcct-3′ (c-myc).
Copulation was determined by the presence of a vaginal plug, and
embryonic day zero (E0) was assumed to be midnight, themidpoint of
the dark portion of the dark–light cycle. Embryos were collected from
the oviducts or uteri of the female mice at various times (embryonic
days) after mating. For the determination of methylation of TR2+
3Igmyc maternal transgene alleles, metaphase II (MII) oocytes from
carrier females were collected following superovulation or carrier
females were crossed with wild-type FVB/N males and embryos
from various preimplantation stages collected as previously
described (Clarke et al., 1992). For allele-speciﬁc methylation and
expression studies, morulae, blastocysts and post-implantation
embryos were obtained from crosses with Dnmt1Δ1o/Δ1o 129/Sv
females and CAST7 males, and from crosses with 129/Sv females
and CAST7 males. CAST7 is a mouse strain in which two Mus
musculus castaneus (CAST) chromosomes 7 reside on a C57BL/6
background (Mann et al., 2003). All experiments were performed
in compliance with guidelines established by the Canadian Council
of Animal Care and the Institutional Animal Care and Use
Committee of the University of Pittsburgh.
Determination of allele-speciﬁc methylation from morulae,
post-implantation embryos and placentae
DNA was isolated from pools of 8–13 morulae using the QIAamp
DNA Micro Kit (Qiagen) and from whole E7.5 embryos or one sagital
half of E9.5 embryos and placentae using the DNeasy Kit (Qiagen).
The whole DNA from pools of morulae or 100 ng from the post-
implantation embryos was used for bisulﬁte treatment using the
EpiTect Bisulﬁte Kit (Qiagen) according to the manufacturer's
protocol. Following bisulﬁte treatment nested PCR ampliﬁcation of
the H19 and Snurf/Snrpn DMDs was performed as previouslydescribed (Lucifero et al., 2002). The presence of both alleles in the
PCR product was conﬁrmed using restriction fragment length
polymorphisms generated by SNPs between 129/Sv and CAST7
strains. 5 μl of the PCR products puriﬁed with MinElute Gel Extraction
Kit (Qiagen) were digested with either DpnII for H19 or SwaI for
Snurf/Snrpn and run on 1.5% agarose gels. For each sample, at least
two different PCR ampliﬁcation products were used to generate the
results. The DNA was subcloned using the TOPO TA Cloning Kit
(Invitrogen) and plasmids containing the appropiate insert were
sequenced using the Big Dye Terminator v3.1 Kit (Applied Biosys-
tems) and run on the ABI 3700 capillary sequencer. Statistically
signiﬁcant differences among samples were determined using the
Mann–Whitney U-test comparing wild-type vs. DNMT1o-deﬁcient
samples. In Figs. 5, 6 and S2, ⁎ denotes signiﬁcantly different levels of
CpGs methylation (pb0.05), ⁎⁎ denotes highly signiﬁcant differences
(pb0.01) and ns=not statistically signiﬁcant differences (pN0.05).
Determination of TR2+3Igmyc transgene methylation
DNA was isolated from pools of 25 MII oocytes or 10–15
preimplantation embryos and used for sodium bisulﬁte mutagenesis
using the EpiTect Bisulﬁte Kit (Qiagen). For TR2+3Igmyc, a semi-nested
strategy was employed using outside primers 1A: 5′-gtattgaaatt-
gagtttgaagtgg-3′ and 2D: 5′-atactctaaataacctaaaaaatcc-3′, and inside
primers 1A and 2C: 5′-tatcttcacctaaaaaccctccac-3′. The PCR conditions
used were 2 cycles of 94°C for 4 min, 55°C for 2 min, and 72°C for
2min, followed by 35 cycles of 94°C for 1min, 55°C for 2min, and 72°C
for 2 min, with a ﬁnal extension of 72°C for 10 min. For the nested
round of PCR the cycling conditions were as follows: 5 min at 94°C
followed by 35 cycles of 94°C for 1 min, 55°C for 2 min, and 72°C for
2 min, with a ﬁnal extension of 72°C for 10 min. The PCR products
were cloned and analyzed with the same methods described before
for endogenous genes. The Kruskal–Wallis test followed by Dunn's
multiple comparison test were performed to test the differences
between all DNMT1o-deﬁcient samples. ⁎ denotes signiﬁcantly
different levels of CpGs methylation (pb0.05). ⁎⁎ denotes highly
signiﬁcant differences (pb0.01). ns=not statistically signiﬁcant differ-
ences (pN0.05).
Determination of allele-speciﬁc expression in single blastocysts
Individual blastocyst stage embryos were placed in 100 μl Dynal
Lysis Buffer, and a solid-phase cDNA library was generated as
described (Mann et al., 2003). The H19 and Snurf/Snrpn expression
assays were conducted on second-strand product using the Light-
Cycler Real Time PCR System. The H19 and Snurf/Snrpn assays was
performed essentially as described (Mann et al., 2003) except for the
Snurf/Snrpn assay where a ﬁnal concentration of 10% DMSO was
used, ampliﬁcationwas performed for 48 cycles and the melting curve
analysis was performed as follows. A ﬁnal denaturation step was
conducted at 95 °C for 1 min, followed by a single annealing step at
40 °C for 1 min and a melting curve analysis with ﬂuorescence
acquisition occurring continuously as the temperature was increased
from 40 °C to 85 °C in 0.2 °C increments. Parental allele-speciﬁc
expression patterns for all genes were calculated as the percent
expression of the 129/Sv or CAST allele relative to the total expression
of both alleles.
For PCR analysis of Peg3, 2× reverse primer and [32P]dCTP (1 mCi)
were added to a Ready-To-Go PCR Bead. Ten microliters of 2× reverse
primer-PCR reactionmix was added to the second-strand product that
contained 2× forward primer, resulting in a ﬁnal concentration of
0.3 mM for each primer. Peg3 primers, Pg11: 5′-aaggctctggttga-
cagtcgtg-3′ and Pg12: 5′-ttctccttggtctcacgggc-3′, were used to amplify
a 224 bp fragment (94 °C for 2 min followed by 34 cycles at 94 °C for
15 s, 52°C for 10 s and 72°C for 20 s). This amplicon contains a
polymorphism between 129/Sv (A) and CAST (G) at position 3451
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76 bp fragments in CAST while the 129/Sv amplicon was uncleaved.
Products were resolved on a 7% polyacrylamide gel. The relative band
intensities were quantitated after a 16 h exposure using ImageQuant
(Molecular Dynamics). Differences in the Peg3 expression levels
between DNMT1o-deﬁcient and control blastocysts were evaluated
by the student t-test.
Determination of allele-speciﬁc expression in post-implantation embryos
and placentae
RNA was isolated from the other sagital half of the same E9.5
embryos and placentae and from whole E7.5 embryos using the
HighPure RNA Tissue Kit (Roche Applied Science). cDNA was
synthetized from the isolated RNA by using Superscript II Reverse
Transcriptase and oligo-dT (Invitrogen). Allele-speciﬁc H19 and Snurf/
Snrpn expression were assessed on cDNA by ﬂuorescent hybridization
probe analysis using the LightCycler Real Time PCR system (Roche
Applied Science) as described abovewithout the addition of DMSO for
the Snurf/Snrpn assay.
Derivation of DNMT1o-deﬁcient ES Cell Lines
ES cell lines were generated from crosses between either wild-type
or homozygous Dnmt1Δ1o/Δ1o 129/Sv female mice and 129/Sv wild-
typemalemice. Wild-type or DNMT1o-deﬁcient E3.5 blastocysts from
these crosses were collected from the uteri, and ES lines established
using previously published methods (Nagy et al., 2003). Each line is
representative of one blastocyst. Individual ES cell clones of bothwild-
type and DNMT1o-deﬁcient lines were isolated by plating ES cells at a
very low density and allowing sufﬁcient time for new colonies to form.
Each ES cell clone is a single colony isolated from the original ES cell
lines and expanded for isolation of DNA.
Southern blot analysis
For extraction of DNA from ES cells lines and clones, cells were
plated in gelatinized plates without feeders. For Snurf/Snrpnmethyla-
tion analysis, 5 μg DNA were digested with PstI and the methylation
sensitive enzyme HhaI, electrophoresed on 1% agarose gel and
transferred to Genescreen nylon membrane (NEN, Boston MA). The
membranes were hybridized with a [32P]dCTP labeled probe to the 5′-
end of the Snurf/Snrpn gene (GenBank accesion no. AF081460). For
H19 methylation analysis, 5 μg DNA were digested with MspI and
HhaI, electrophoresed on 1.5% agarose gels, transferred and hybridized
with a [32P]dCTP labeled probe to the 5′ non-transcribed region of the
H19 gene between nucleotides 1216 and 2387 (GenBank accession no.
U19619). For the analysis of repetitive sequences (IAP and LINE-1),1 μg
of DNA was used for MspI or HpaII digests, electrophoresed on 1%
agarose gel and following transfer, hybridized with a [32P]dCTP
labeled probe to the LTR sequence of the agouti Aiapy allele for IAP
(Michaud EJ, 1994), or a probe to LINE-1 repeats between nucleotides
6477 and 7092 (GenBank accession no. M29324).
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